Migraine and the Gut–Brain Axis—The Role of Microbiome-Targeted Biotics
Nutrients · 24.02.2026 · 18 (5) · 720
DOI: 10.3390/nu18050720 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 24.02.2026. Verfasst von Márk Kozák und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectology, Faculty of Medicine, University of Debrecen, Bartok Bela Street 2-26, 4031 Debrecen, Hungary. Hauptthemen laut MEDLINE: Migraine Disorders, Probiotics, Gastrointestinal Microbiome, Brain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MTE-DE Lendület “Momentum” Research Group, National Research, Development and Innovation Fund, MTA-DE HUN-REN Cerebrovascular Research Group.
Abstract (Originalsprache)
Background
Migraine is a highly prevalent and disabling primary headache disorder frequently accompanied by gastrointestinal symptoms and comorbid gastrointestinal diseases. Increasing evidence suggests that alterations in the gut microbiota and dysregulation of the microbiome–gut–brain axis may contribute to migraine pathophysiology through immune activation, oxidative stress, impaired intestinal barrier function, and neuroinflammatory signaling.
Objectives
This narrative review aims to summarize current mechanistic and clinical evidence linking the gut–brain axis to migraine, with a particular focus on the potential roles of probiotics, prebiotics, and postbiotics as adjunctive strategies in migraine management.
Methods
A narrative synthesis of experimental, translational, and clinical studies was performed, focusing on microbiome composition, gut barrier integrity, immune and oxidative pathways, and interventional trials evaluating probiotics, prebiotics, synbiotics, and microbiota-derived metabolites in adult and pediatric migraine populations.
Results
Migraine has been associated with intestinal dysbiosis, increased gut permeability, and low-grade systemic inflammation. Probiotics, most commonly strains of Lactobacillus and Bifidobacterium, may modulate inflammatory cytokine profiles, enhance tight junction integrity, reduce oxidative stress, and influence neurotransmitter-related pathways along the gut–brain axis. Clinical trials evaluating probiotic supplementation report heterogeneous but promising signals, including reductions in migraine frequency, severity, disability scores, and analgesic use, particularly in chronic migraine and pediatric populations. Emerging evidence also supports a potential role for prebiotics (e.g., inulin-type fructans) and microbiota-derived metabolites such as short-chain fatty acids, although direct clinical data remain limited.
Conclusions
Modulation of the microbiome–gut–brain axis represents a biologically plausible adjunct approach in migraine management. While probiotics, prebiotics, and postbiotics show potential benefits with favorable safety profiles, current evidence of their strain-, formulation-, and population-specific characteristics is lacking. Well-powered, placebo-controlled trials with standardized migraine endpoints and integrated microbiome and metabolomic analyses are needed to define responders, optimal interventions, and clinical relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectology, Faculty of Medicine, University of Debrecen, Bartok Bela Street 2-26, 4031 Debrecen, Hungary.
- Division of Clinical Laboratory Sciences, Department of Laboratory Medicine, Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
- MTA-DE Lendület "Momentum" Hemostasis and Stroke Research Group, 4032 Debrecen, Hungary.
- Faculty of Medicine, University of Debrecen, 4032 Debrecen, Hungary.
ORCID-Profile: Márk Kozák, Zsolt Barta
Förderung
- MTE-DE Lendület “Momentum” Research Group
- National Research, Development and Innovation Fund
- MTA-DE HUN-REN Cerebrovascular Research Group
- Gedeon Richter Talentum Foundation
- the Ministry for Culture and Innovation
Zitieren
APA
Kozák, M., Sitku, T., Hodossy-Takács, R., Sápi, F., Várkonyi, I., & Barta, Z. (2026). Migraine and the Gut–Brain Axis—The Role of Microbiome-Targeted Biotics. Nutrients, 18(5), 720. https://doi.org/10.3390/nu18050720
Vancouver
Kozák M, Sitku T, Hodossy-Takács R, Sápi F, Várkonyi I, Barta Z. Migraine and the Gut–Brain Axis—The Role of Microbiome-Targeted Biotics. Nutrients. 2026;18(5):720. doi:10.3390/nu18050720
BibTeX
@article{Kozk2026,
author = {Kozák, Márk and Sitku, Tímea and Hodossy-Takács, Rebeka and Sápi, Flóra and Várkonyi, István and Barta, Zsolt},
title = {Migraine and the Gut–Brain Axis—The Role of Microbiome-Targeted Biotics},
journal = {Nutrients},
year = {2026},
volume = {18},
number = {5},
pages = {720},
doi = {10.3390/nu18050720}
}
EUVIMED